Immunization of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses.

Immunization of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses.

OBJECTIVE: To evaluate the immune response to HIV-1 p24 generated in vivo by p17/p24:Ty virus-like particles (p17/p24:Ty-VLP) by examining the lymphoproliferative and antibody (Ab) responses to HIV-1 p24, as well as Gag-specific cytotoxic T lymphocytes (CTL), in HIV-seronegative volunteers immunized...

Bibliografski detalji
Glavni autori:	Martin, S, Vyakarnam, A, Cheingsong-Popov, R, Callow, D, Jones, K, Senior, J, Adams, SE, Kingsman, A, Matear, P, Gotch, F
Format:	Journal article
Jezik:	English
Izdano:	1993

Slični predmeti

T cell responses to peptides covering the gag p24 region of HIV-1 occur in HIV-1 seronegative individuals.
od: Vyakarnam, A, i dr.
Izdano: (1991)

A novel method for the purification of HIV-1 p24 protein from hybrid Ty virus-like particles (Ty-VLPs).
od: Gilmour, J, i dr.
Izdano: (1989)

Immunization with recombinant p17/p24:Ty virus-like particles in human immunodeficiency virus-infected persons.
od: Veenstra, J, i dr.
Izdano: (1996)

The expression of hybrid HIV:Ty virus-like particles in yeast.
od: Adams, SE, i dr.
Izdano: (1987)

Immune responses in HIV-exposed seronegatives: have they repelled the virus?
od: Rowland-Jones, S, i dr.
Izdano: (1995)

Cell-Penetrating Antibodies For Targeting HIV-1 P24 Capsid Protein
od: Teow, Sin Yeang
Izdano: (2015)

Cell-Penetrating Antibodies For Targeting Hiv-1 P24 Capsid Protein
od: Teow , Sin Yeang
Izdano: (2015)

Innate immunity against HIV: a priority target for HIV prevention research.
od: Borrow, P, i dr.
Izdano: (2010)

Enhanced immune activation linked to endotoxemia in HIV-1 seronegative men who have sex with men
od: Palmer, Christine D., i dr.
Izdano: (2015)

Cell-mediated immunity in HIV seronegative patients recovered from Cryptococcus neoformans var. gattii meningitis
od: Seaton, R, i dr.
Izdano: (1997)

Cell-mediated immunity in HIV seronegative patients recovered from Cryptococcus neoformans var. gattii meningitis.
od: Seaton, R, i dr.
Izdano: (1997)

Comparison of p24 measurement by ELISA versus indicator cells for detecting residual HIV infectivity in vitro.
od: Herbein, G, i dr.
Izdano: (1996)

Characterization Of Recombinant Antibodies Targeting Hiv-1 Capsid Protein (P24): Towards The Development Of Antibody-Based Therapy Against Hiv/Aids
od: Mualif, Siti Aisyah
Izdano: (2017)

The immune response to HIV
od: McMichael, A, i dr.
Izdano: (2009)

HIV. The immune response.
od: Mcmichael, A
Izdano: (1996)

pTHr.HIVA and MVA.HIVA vaccines (gag p24/p17) augment CD4+T cell responses in chronically infected HIV-1 patients on HAART
od: Ondondo, B, i dr.
Izdano: (2005)

The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity.
od: Parren, P, i dr.
Izdano: (1999)

Immunity to infection genetic effects on immunity HIV
od: Greaves, D
Izdano: (1999)

Improved quantification of HIV-1-infected CD4+ T cells using an optimised method of intracellular HIV-1 gag p24 antigen detection.
od: Yang, H, i dr.
Izdano: (2013)

Improved quantification of HIV-1-infected CD4+ T cells using an optimised method of intracellular HIV-1 gag p24 antigen detection
od: Yang, H, i dr.
Izdano: (2013)

Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization
od: Turner, Hannah L., i dr.
Izdano: (2021)

Differences in HIV-specific T cell responses between HIV-exposed and -unexposed HIV-seronegative individuals.
od: Ritchie, A, i dr.
Izdano: (2011)

Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57.
od: Gillespie, G, i dr.
Izdano: (2002)

Immunity to HIV in early life
od: Muenchhoff, M, i dr.
Izdano: (2014)

HIV infection and the immune system.
od: Sattentau, Q
Izdano: (1989)

IMMUNE ESCAPE IN HIV-INFECTION
od: Lalloo, D, i dr.
Izdano: (1995)

Cellular immune responses to HIV.
od: Mcmichael, A, i dr.
Izdano: (2001)

Psychiatric and substance abuse comorbidity among HIV seropositive and HIV seronegative prisoners in Malaysia
od: Zahari, M.M., i dr.
Izdano: (2010)

The production of hybrid Ty:IFN virus-like particles in yeast.
od: Malim, M, i dr.
Izdano: (1987)

Molecular screening for microdeletions at 9p22-p24 and 11q23-q24 in a large cohort of patients with trigonocephaly.
od: Jehee, F, i dr.
Izdano: (2005)

Web alert. Immunity to infection. Genetic effects on immunity. HIV.
od: Greaves, D
Izdano: (1997)

HIV. Genetic effects on immunity immunity to infection. Web alert.
od: Greaves, D
Izdano: (1998)

Seronegative antibody‐mediated neurology after immune checkpoint inhibitors
od: Wilson, R, i dr.
Izdano: (2018)

Immunoadsorption and plasma exchange in seropositive and seronegative immune-mediated neuropathies
od: Davies, A, i dr.
Izdano: (2020)

P4−24: Vulnerability to electric shocks in regional ischemia
od: Rodriguez, B, i dr.
Izdano: (2006)

Assessment of mucosal immunity to HIV-1.
od: Jespers, V, i dr.
Izdano: (2010)

How HIV defeats the immune system.
od: Nowak, M, i dr.
Izdano: (1995)

Escape from immune control by HIV
od: McMichael, A, i dr.
Izdano: (1997)

The humoral immune response to BCG vaccination
od: Tanner, R, i dr.
Izdano: (2019)

Generation And Evaluation Of A Functional Single-Chain Variable Fragment (scFv) Intrabody Against HIV-1 Capsid Protein (P24).
od: Che Omar, Mohammad Tasyriq
Izdano: (2017)